Sleeping Bruxism Treatment Market Report Scope & Overview:

Sleeping Bruxism Treatment Market is valued at USD 652.14 Million in 2025E and is expected to reach USD 1132.09 Million by 2033, growing at a CAGR of 7.18% from 2026-2033. 

The Sleeping Bruxism Treatment Market is growing due to increasing awareness of sleep-related disorders and their impact on oral health, including tooth wear, jaw pain, and headaches. Rising stress levels, lifestyle changes, and growing prevalence of bruxism are driving demand for therapeutic interventions such as oral appliances, medications, and behavioral therapies. Additionally, advancements in diagnostic technologies, growing adoption of home-based monitoring solutions, and increasing dental healthcare access are further fueling market growth globally.

In 2024, over 45% of dentists reported increased patient consultations for bruxism-related symptoms, spurring a 20% rise in custom oral appliance prescriptions and a 35% growth in tele-dental behavioral therapy adoption worldwide.

Sleeping Bruxism Treatment Market Size and Forecast

• Market Size in 2025E: USD 652.14 Million

• Market Size by 2033: USD 1132.09 Million

• CAGR: 7.18% from 2026 to 2033

• Base Year: 2025E

• Forecast Period: 2026–2033

• Historical Data: 2022–2024

Sleeping Bruxism Treatment Market Trends

• Rising preference for non-invasive oral appliances and custom dental splints as first-line therapy for nighttime teeth grinding

• Increasing adoption of biofeedback and smart wearable devices enabling sleep bruxism monitoring and behavioral modification

• Growing use of botulinum toxin injections to reduce jaw muscle hyperactivity and alleviate chronic bruxism symptoms

• Expansion of tele-dentistry and remote diagnostics to improve access to sleep disorder evaluations and treatment follow-ups

• Integration of AI-enabled sleep tracking platforms for real-time bruxism detection and personalized treatment optimization

U.S. Sleeping Bruxism Treatment Market is valued at USD 208.68 Million in 2025E and is expected to reach USD 357.56 Million by 2033, growing at a CAGR of 7.01% from 2026-2033. 

Growth in the U.S. Sleeping Bruxism Treatment Market is driven by rising awareness of sleep disorders and their impact on oral health. Increasing stress levels, lifestyle changes, and adoption of therapeutic solutions such as oral appliances and behavioral therapies are further boosting market demand.

Sleeping Bruxism Treatment Market Growth Drivers:

• Rising prevalence of sleep disorders and bruxism globally is driving demand for effective treatments, including occlusal splints, behavioral therapy, and pharmacological interventions

The growing incidence of bruxism and related sleep disorders is increasing the need for effective treatment options. Occlusal splints and night guards are widely prescribed to prevent tooth damage, while behavioral therapy and pharmacological interventions address underlying causes. Rising stress levels, lifestyle changes, and poor sleep hygiene contribute to higher prevalence rates, prompting both patients and dental professionals to seek therapeutic solutions. As awareness of bruxism’s long-term dental and musculoskeletal consequences grows, demand for reliable, clinically proven treatments continues to expand across global markets.

In 2024, global bruxism prevalence reached an estimated 20% of adults, driving a 22% increase in occlusal splint prescriptions and a 28% rise in demand for behavioral and pharmacological therapies to manage sleep-related grinding and clenching.

• Increasing awareness among patients and dental professionals about the consequences of untreated bruxism is boosting adoption of advanced therapeutic and diagnostic solutions

Awareness campaigns, educational initiatives, and dental consultations are highlighting the risks of untreated bruxism, including tooth wear, jaw pain, headaches, and sleep disruption. As patients become more informed, they are more likely to seek professional evaluation and adopt recommended therapies. Dental professionals are increasingly leveraging advanced diagnostic tools and treatment options, such as biofeedback devices, digital monitoring, and custom-fitted occlusal splints. This combination of patient and provider awareness is driving higher adoption rates, supporting market growth, and encouraging investment in innovative therapeutic and diagnostic solutions for effective bruxism management.

In 2024, 70% of dental practices reported higher patient inquiries about bruxism, driving a 30% increase in adoption of advanced diagnostics like EMG-based sleep monitors and custom therapeutic solutions such as 3D-printed occlusal splints.

Sleeping Bruxism Treatment Market Restraints:

• High cost of specialized treatments, limited insurance coverage, and out-of-pocket expenses restrict accessibility for patients, limiting overall market growth in some regions

Specialized bruxism treatments, including custom-fitted occlusal splints, biofeedback devices, and clinical therapies, often involve significant expenses. Limited insurance reimbursement for these procedures increases out-of-pocket costs, making treatments less affordable for a large patient population. High costs can discourage adoption, particularly in emerging markets or low-income regions, where financial constraints are prevalent. Additionally, expensive diagnostic procedures and follow-up consultations add to the overall burden. These financial barriers restrict patient access, limit market penetration, and slow growth, despite rising prevalence and increasing demand for effective bruxism management solutions.

In 2024, over 55% of patients in key markets cited high out-of-pocket costs—often exceeding USD500 for custom splints and limited insurance coverage as barriers, leading to delayed treatment and constrained market expansion in cost-sensitive regions.

• Lack of patient compliance and awareness regarding long-term treatment adherence reduces effectiveness of therapies and may hinder treatment adoption rates

Successful bruxism management often requires consistent use of night guards, adherence to behavioral therapies, and routine follow-up appointments. Many patients discontinue treatment due to discomfort, inconvenience, or lack of understanding of the long-term benefits. Inadequate compliance reduces therapeutic effectiveness, potentially leading to recurring symptoms and diminished patient satisfaction. Low adherence can discourage healthcare providers from recommending advanced or costly treatment options. Consequently, patient behavior and awareness play a critical role in market growth, with poor compliance representing a significant restraint to the widespread adoption of sleeping bruxism treatment solutions globally.

In 2024, nearly 50% of bruxism patients discontinued therapy within six months due to low symptom awareness and discomfort, reducing treatment efficacy and limiting sustained adoption of long-term interventions like oral appliances and behavioral programs.

Sleeping Bruxism Treatment Market Opportunities:

• Technological advancements in occlusal splints, biofeedback devices, and digital diagnostics offer opportunities for innovative, patient-friendly bruxism treatment solutions

Innovation in bruxism management is creating opportunities to develop more effective, convenient, and personalized treatments. Advanced occlusal splints with improved comfort, wearable biofeedback devices that monitor jaw activity, and digital diagnostics for early detection are transforming therapy. These technologies enhance patient experience, improve adherence, and provide measurable treatment outcomes. Integration with mobile applications and tele-dentistry platforms further increases accessibility and engagement. As consumers increasingly seek non-invasive, convenient, and effective solutions, companies investing in technology-driven innovations can differentiate their offerings, attract more patients, and expand their market presence globally.

In 2024, 60% of dental clinics adopted digitally designed occlusal splints and AI-enhanced diagnostics, while biofeedback devices saw a 35% rise in use improving patient comfort, compliance, and early bruxism detection rates globally.

• Rising geriatric population and increasing prevalence of stress-related sleep disorders globally provide significant potential for market expansion and product diversification

An aging population is more prone to dental issues and sleep disorders, including bruxism, creating a growing target market for specialized treatments. Additionally, stress and lifestyle changes are contributing to higher bruxism prevalence across younger demographics. This dual trend supports demand for both preventive and therapeutic interventions. Companies can develop age-specific and condition-specific solutions, such as customized night guards, biofeedback devices, and combination therapies. By addressing the needs of diverse patient segments and increasing awareness of treatment benefits, the market can experience significant expansion, product diversification, and long-term revenue growth.

In 2024, adults aged 60+ accounted for 30% of bruxism cases, while stress-related sleep disorders rose by 25% globally driving demand for tailored therapies and spurring development of age-specific and stress-targeted bruxism treatment solutions.

Sleeping Bruxism Treatment Market Segment Highlights

• By Product: Occlusal Splints & Night Guards led with 41.8% share, while Biofeedback Therapy Devices is the fastest-growing segment with CAGR of 10.6%.

• By Diagnosis Type: Polysomnography led with 39.3% share, while Home Sleep Monitoring Devices is the fastest-growing segment with CAGR of 11.2%.

• By Age Group: Adults led with 52.7% share, while Pediatrics / Children is the fastest-growing segment with CAGR of 9.8%.

• By Distribution Channel: Hospitals & Dental Clinics led with 46.1% share, while Online Pharmacies is the fastest-growing segment with CAGR of 10.9%.

Sleeping Bruxism Treatment Market Segment Analysis

By Product: Occlusal Splints & Night Guards led, while Biofeedback Therapy Devices is the fastest-growing segment.

Occlusal Splints & Night Guards dominate the product landscape because they provide immediate relief, are cost-effective, and remain the preferred first-line treatment recommended by dentists and sleep specialists. Their non-invasive nature, customizable fit, and high availability through hospitals, dental clinics, and both offline and online pharmacies further support their widespread adoption. They also suit patients across all age groups, making them the most accessible and clinically trusted solution for managing sleep bruxism.

Biofeedback Therapy Devices represent the fastest-growing product category due to increasing adoption of wearable and neurofeedback-based technologies that enable long-term behavioral reconditioning. These devices support continuous muscle monitoring, sleep pattern analysis, and remote therapy integration, helping patients reduce nighttime teeth grinding without relying solely on splints. Rising preference for digital therapy, growing awareness of habit-reversal training, and compatibility with mobile health platforms are accelerating their demand across both home and clinical environments.

By Diagnosis Type: Polysomnography led, while Home Sleep Monitoring Devices is the fastest-growing segment.

Polysomnography remains the dominant diagnosis method because it offers gold-standard measurement of sleep bruxism by capturing EEG activity, jaw muscle movement, breathing, and sleep stages with unmatched precision. It is widely used in hospitals and sleep laboratories for diagnosing moderate to severe cases where detailed physiological monitoring is required. Physicians prefer polysomnography due to its high clinical accuracy, ability to rule out associated sleep disorders, and essential role in developing personalized treatment recommendations.

Home Sleep Monitoring Devices are the fastest-growing diagnosis category as patients increasingly seek affordable, comfortable, and continuous tools for tracking bruxism outside clinical settings. Their integration with mobile apps, AI-based scoring, and remote physician review improves accessibility and patient engagement. They support early screening, long-term monitoring, and therapy progress evaluation, making them particularly attractive to users with recurring symptoms or mild to moderate bruxism who want convenient, technology-supported diagnosis.

By Age Group: Adults led, while Pediatrics / Children is the fastest-growing segment.

Adults account for the dominant share in the sleeping bruxism treatment market due to higher exposure to stress, anxiety, and lifestyle triggers linked with work pressure, poor sleep habits, and emotional strain. This age group demonstrates greater treatment awareness and willingness to seek diagnosis compared with pediatric and geriatric demographics. Increasing use of oral appliances, medications, and behavioral therapy among working adults reinforces their market lead, supported by rising healthcare spending and proactive wellness-seeking behavior.

Pediatrics / Children represent the fastest-growing segment as awareness increases among parents and pediatric dentists regarding early-onset bruxism and its potential impact on dental development, sleep quality, and behavior. Early screening programs, customized pediatric night guards, and behavioral sleep-hygiene interventions are gaining momentum. Growth is also supported by school-based health programs and pediatric orthodontic monitoring, encouraging early management. As diagnosis becomes more common, treatment adoption is rapidly expanding in younger populations.

By Distribution Channel: Hospitals & Dental Clinics led, while Online Pharmacies is the fastest-growing segment.

Hospitals & Dental Clinics dominate because they provide expert-guided diagnosis, personalized fitting of oral appliances, and multidisciplinary care for moderate and severe bruxism cases. Their access to advanced technologies such as polysomnography and EMG strengthens clinical accuracy and treatment adherence. Patients favor these facilities for professional oversight, follow-up sessions, and comprehensive care plans that combine splints, therapy, and medication, making them the primary channel for structured and long-term bruxism management.

Online Pharmacies are the fastest-growing channel due to rising demand for convenient access to night guards, medications, biofeedback devices, and home-monitoring tools. Digital purchasing enables privacy, home delivery, wide product comparison, and discounts, which appeal strongly to busy adults and individuals seeking self-managed treatment options. Growing consumer trust in e-pharmacy platforms, combined with subscription-based replenishment for oral appliances and therapy accessories, continues to accelerate online sales in the sleeping bruxism treatment market.

Sleeping Bruxism Treatment Market Regional Analysis

North America Sleeping Bruxism Treatment Market Insights:

North America dominated the Sleeping Bruxism Treatment Market with the highest revenue share of about 40.00% in 2025 due to the high prevalence of stress-induced sleep disorders, strong awareness of oral health, and widespread access to advanced dental care. High adoption of occlusal splints, insurance coverage for dental treatments, and the presence of leading therapeutic device manufacturers further strengthen regional market leadership.

Asia Pacific Sleeping Bruxism Treatment Market Insights

Asia Pacific is expected to grow at the fastest CAGR of about 9.25% from 2026-2033 owing to rising cases of anxiety-related bruxism, increasing dental care expenditure, and growing penetration of sleep medicine services. Expanding urban populations, improved access to orthodontic and behavioral therapies, and strong government focus on sleep health awareness continue to accelerate adoption across emerging economies.

Europe Sleeping Bruxism Treatment Market Insights

Europe accounted for a significant share in the Sleeping Bruxism Treatment Market in 2025 supported by strong dental infrastructure, high awareness of sleep-related disorders, and widespread adoption of preventive oral care products. The region benefits from reimbursement for dental therapies, rapid uptake of digital sleep monitoring technologies, and a rising geriatric population prone to bruxism. Continuous clinical innovation, strong presence of orthodontic specialists, and government programs promoting oral health sustain steady market expansion across major economies.

Middle East & Africa and Latin America Sleeping Bruxism Treatment Market Insights

Middle East & Africa and Latin America (combined) are witnessing steady growth in the Sleeping Bruxism Treatment Market driven by increasing recognition of sleep disorders, rising stress levels among working populations, and growing adoption of dental diagnostics. Expanding private healthcare facilities, rising medical tourism for orthodontic treatments, and increasing sales of affordable mouthguards online contribute to higher treatment penetration. Gradual improvements in healthcare spending and the presence of international dental brands support continued long-term market development across these regions.

Sleeping Bruxism Treatment Market Competitive Landscape:

Ivoclar Vivadent AG

Ivoclar Vivadent AG, headquartered in Liechtenstein, is a leading global dental company specializing in preventive, restorative, and prosthetic dental solutions. In the bruxism treatment market, it provides high-quality occlusal splints, night guards, and custom dental appliances designed to reduce teeth grinding and jaw tension during sleep. Known for innovative materials and precision engineering, Ivoclar Vivadent emphasizes patient comfort and safety while supporting dental professionals worldwide with reliable, clinically proven products to manage and prevent the adverse effects of bruxism.

• 2024, Ivoclar Vivadent launched Bruxir Advanced, a next-generation custom-fitted night guard for managing sleep bruxism, fabricated using intraoral scan data and 3D printing.

Henry Schein, Inc.

Henry Schein, Inc., based in the United States, is a global distributor of healthcare products and dental solutions, including bruxism treatment devices. The company offers a wide range of night guards, oral appliances, and related dental equipment to help prevent teeth grinding and jaw discomfort. With a focus on quality, accessibility, and innovation, Henry Schein serves dental professionals globally, providing reliable products and support to improve patient outcomes, streamline clinic workflows, and promote oral health management for bruxism patients.

• 2025, Henry Schein introduced Schein Sleep Solutions, a practice support program helping dentists screen, diagnose, and treat sleep-related disorders including sleep bruxism and obstructive sleep apnea (OSA).

Pfizer Inc.

Pfizer Inc., a multinational pharmaceutical company headquartered in the United States, is widely recognized for its research and development of therapeutic solutions, including those addressing sleep-related conditions and muscle relaxation. In the context of bruxism treatment, Pfizer focuses on pharmacological interventions and supportive therapies that alleviate jaw muscle tension and reduce teeth grinding during sleep. Leveraging its strong global presence, extensive R&D capabilities, and commitment to patient safety, Pfizer provides innovative solutions to improve the quality of life for individuals affected by bruxism worldwide.

• 2024, Pfizer announced a non-exclusive research collaboration with the International Sleep Research Consortium (ISRC) to investigate biomarkers associated with sleep-related movement disorders, including nocturnal bruxism.

Sleeping Bruxism Treatment Market Key Players

Some of the Sleeping Bruxism Treatment Market Companies are:

• Ivoclar Vivadent AG

• Ipsen Biopharmaceuticals, Inc.

• Merz Pharma GmbH & Co. KGaA

• Carestream Dental

• Akervall Technologies Inc.

• PLANMECA OY

• Randmark Dental Products, LLC

• S4S (UK) Limited

• Patterson Dental Supply, Inc.

• Henry Schein, Inc.

• Pfizer Inc.

• Glidewell Dental

• Dentsply Sirona

• Randmark Dental Treatment Types, LLC

• Procter & Gamble

• SelfSense Technologies

• Ohlendorf Appliance Laboratory

• Panthera Dental

• byteSense

• The Doctor’s Night Guard